Vancomycin AUC-guided therapeutic drug monitoring to reduce nephrotoxicity: are we overlooking a simpler solution? Comment on: Oda K, Jono H, Nosaka K, Saito H. Reduced nephrotoxicity in vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against trough 15-20 µg/mL concentration

MeSH terms

• Anti-Bacterial Agents / adverse effects*
• Anti-Bacterial Agents / therapeutic use
• Area Under Curve
• Drug Monitoring / methods*
• Humans
• Kidney / drug effects*
• Microbial Sensitivity Tests
• Renal Insufficiency / chemically induced*
• Renal Insufficiency / prevention & control
• Vancomycin / adverse effects*
• Vancomycin / therapeutic use